Urine test identifies more than nine in ten bladder cancers, clinical study finds

New research has found that more than 9 in 10 patients with bladder cancer were identified through a noninvasive urine test after urgent referral. The study, led by the University of Birmingham and Nonacus Ltd., involved 964 patients across seven NHS urology departments to examine the real-world significance of testing for bladder cancer using a commercially available urine test. GALEAS™ Bladder, which tests genomic information from a patient's urine for traces of bladder cancer, detected 71 of 77 cancers (92.2%) among the nearly 1,000 patients.

Read it at Medical Xpress ↗

← Front page